FAIL (the browser should render some flash content, not this).

TEL:021-62717659 62717125 62720751
E-MAIL:susanxi@unistarholdings.cn

 
FAIL (the browser should render some flash content, not this).

About nistar

  Unistar (China) Holdings Ltd is a Sino-foreign joint venture enterprise specializing in investment and management of large medical laser devices, medical cosmetics and anti-aging medical services. Unistar primarily focuses on the sectors of medical project investment and management as well as medical technical training. The business scope of Unistar mainly includes plastic surgery, laser aesthetics, ophthalmic refractive laser surgery, anti-aging medical services and so on. Up to now, Unistar's investment projects have covered more than 20 domestic provinces, cities, autonomous regions and municipalities. Unistar has developed an extensive treatment network and established nearly 30 centers in the area of eye laser surgery, plastic surgery and anti-aging medical services.

  Since its inception, Unistar has brought to China dozens of varieties of the world's most advanced lasers and photonic medical instruments totaling around 500 units by using the method of investment holdings, cooperation leasing and so on. Unistar has cooperated with many hospitals in various parts of China on medical technology projects, especially in ophthalmic area, with 30 of them currently operating well. Unistar has introduced to China advanced medical technologies and management methods to contribute our mission of "Providing high quality services for patients with love ". Up until the end of 2008, Unistar has provided hundreds of thousands of excimer laser treatments for domestic myopia patients and enable them to see a bright new world!

  Over the years, Unistar has been cooperating and liaising with the World Anti-Aging Academy of Medicine. The official partnership was established in 2008, the goal of which is to carry out non-surgical aesthetics and anti-aging medical services and to promote the industrialization of anti-aging and regenerative medicine based on Unistar’s investment projects in China.